TY - JOUR
T1 - The obesity paradox in heart failure patients with preserved versus reduced ejection fraction
T2 - A meta-analysis of individual patient data
AU - Padwal, R.
AU - Mcalister, F. A.
AU - Mcmurray, J. J.V.
AU - Cowie, M. R.
AU - Rich, M.
AU - Pocock, S.
AU - Swedberg, K.
AU - Maggioni, A.
AU - Gamble, G.
AU - Ariti, C.
AU - Earle, N.
AU - Whalley, G.
AU - Poppe, K. K.
AU - Doughty, R. N.
AU - Bayes-Genis, A.
N1 - Funding Information:
FAM is supported by salary awards from Alberta Innovates-Health Solutions and the Capital Health Chair in Cardiovascular Outcomes Research; KKP is supported by a Research Fellowship from the New Zealand Heart Foundation; RND holds the New Zealand Heart Foundation Chair in Heart Health; and MRC is supported by the National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital, London, UK. RP and FAM are supported by an alternate funding plan from the Government of Alberta. The MAGGIC meta-analysis was supported by grants from the New Zealand National Heart Foundation, the University of Auckland and the University of Glasgow.
PY - 2014/8
Y1 - 2014/8
N2 - Background:In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m-2, is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)).Patients and Methods:A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m-2. Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups.Results:BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m-2, the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35.Conclusions:In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m -2.
AB - Background:In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m-2, is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)).Patients and Methods:A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m-2. Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups.Results:BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m-2, the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35.Conclusions:In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m -2.
KW - body mass index; heart failure; prognosis; obesity paradox; ejection fraction
UR - http://www.scopus.com/inward/record.url?scp=84905661153&partnerID=8YFLogxK
U2 - 10.1038/ijo.2013.203
DO - 10.1038/ijo.2013.203
M3 - Article
C2 - 24173404
AN - SCOPUS:84905661153
SN - 0307-0565
VL - 38
SP - 1110
EP - 1114
JO - International Journal of Obesity
JF - International Journal of Obesity
IS - 8
ER -